Combined intravitreal dexamethasone and bevacizumab injection for the treatment of persistent diabetic macular edema (DexaBe study): a phase I clinical study

[1]  Tai-Chi Lin,et al.  Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema , 2021, Acta Diabetologica.

[2]  M. Gillies,et al.  Local delivery of corticosteroids in clinical ophthalmology: A review , 2019, Clinical & experimental ophthalmology.

[3]  E. I. Andrade,et al.  Impacto orçamentário da incorporação de medicamentos para tratamento em segunda linha do edema macular diabético no SUS sob a perspectiva da Secretaria de Estado de Saúde de Minas Gerais, Brasil , 2019, Cadernos de Saúde Pública.

[4]  R. Lira,et al.  Effect of intravitreal dexamethasone solution on the reduction of macular thickness in pseudophakic diabetic patients in a public hospital in Brazil: a randomized clinical trial , 2019, Clinical ophthalmology.

[5]  C. Greven,et al.  Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 μg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I). , 2018, Ophthalmic surgery, lasers & imaging retina.

[6]  J. Ambati,et al.  Pharmacology of Corticosteroids for Diabetic Macular Edema , 2018, Investigative ophthalmology & visual science.

[7]  J. Alexander,et al.  Diabetic retinopathy: Breaking the barrier. , 2017, Pathophysiology : the official journal of the International Society for Pathophysiology.

[8]  S. Vujosevic,et al.  Imaging retinal inflammatory biomarkers after intravitreal steroid and anti‐VEGF treatment in diabetic macular oedema , 2017, Acta ophthalmologica.

[9]  N. Bressler,et al.  Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial , 2017, JAMA ophthalmology.

[10]  Minwen Zhou,et al.  Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis , 2016, Scientific Reports.

[11]  N. Bressler,et al.  Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial. , 2016, JAMA ophthalmology.

[12]  H. Flynn,et al.  Update on corticosteroids for diabetic macular edema , 2016, Clinical ophthalmology.

[13]  N. Bressler,et al.  Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. , 2016, JAMA ophthalmology.

[14]  A. Wenzel,et al.  Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials , 2016, Clinical ophthalmology.

[15]  N. Bressler,et al.  Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema. , 2016, American journal of ophthalmology.

[16]  Arup Das,et al.  Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets. , 2015, Ophthalmology.

[17]  Judy E. Kim,et al.  Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment. , 2015, JAMA ophthalmology.

[18]  M. Gillies,et al.  A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. , 2014, Ophthalmology.

[19]  M. Gillies,et al.  Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema. , 2014, Current molecular medicine.

[20]  S. Bakri,et al.  Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[21]  Quan Dong Nguyen,et al.  Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. , 2012, Ophthalmology.

[22]  U. Kompella,et al.  Trabecular meshwork and lens partitioning of corticosteroids: implications for elevated intraocular pressure and cataracts. , 2011, Archives of ophthalmology.

[23]  H. Tabandeh,et al.  DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS , 2011, Retina.

[24]  Jennifer K. Sun,et al.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. , 2011, Ophthalmology.

[25]  A. Messias,et al.  Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation , 2010, Acta ophthalmologica.

[26]  S. Mohammadi,et al.  Intravitreal Bevacizumab versus Combined Bevacizumab-Triamcinolone versus Macular Laser Photocoagulation in Diabetic Macular Edema , 2008, European journal of ophthalmology.

[27]  George A. Williams,et al.  Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. , 2007, Archives of ophthalmology.

[28]  Daniela Calucci,et al.  Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. , 2005, Investigative ophthalmology & visual science.

[29]  K. Chalam,et al.  Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery. , 2003, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[30]  Jennifer K. Sun,et al.  Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial , 2018, JAMA ophthalmology.

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..